Invitation to presentation in connection with EQL Pharma's interim report, second quarter, 2024/25
EQL Pharma AB (publ) will publish its interim report for the second quarter, 2024/25, on Wednesday, November 6[th], before stock markets opening.
EQL Pharma AB (publ) will publish its interim report for the second quarter, 2024/25, on Wednesday, November 6[th], before stock markets opening.
Today, on 19 August 2024, the annual general meeting was held in EQL Pharma AB. A summary of the adopted resolutions follows below.
Sales and operating profit growth, new products added to the pipeline
The shareholders of EQL Pharma AB, Reg. No. 556713-3425, are hereby invited to the annual general meeting to be held on Monday 19 August 2024 at 16.00 at the company’s premises at Stortorget 1 in L...
EQL Pharma AB (publ) will publish its interim report for the first quarter, 2024/25, on Thursday, August 8[th], before stock markets opening.